Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06785129 · ClinicalTrials.gov registry record

Endometriosis and Migraine

A clinical trial of Migraine and Endometriosis, sponsored by Washington University School of Medicine.

Recruiting
Registry status
120
Enrollment target
1
Study location

NCT06785129 is a study of Migraine and Endometriosis that is actively recruiting participants, run by Washington University School of Medicine. The registered enrollment target is 120 participants, below the 357-participant average among 102 other Migraine trials with a reported enrollment target (66% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06785129, a study of Migraine and Endometriosis, is actively recruiting participants, sponsored by Washington University School of Medicine.

RECRUITING
Registry status
120 participants
Enrollment target
1
Study location

Study Summary

This study aims to determine differences in experimental pain and sex hormone levels between patients with migraine, patients with endometriosis, patients with migraine and endometriosis, and healthy controls. Participants will complete surveys, experimental pain paradigms and collection of samples for hormone analyses.

Conditions Studied

Interventions

  • DEVICE Pressure stimuli
  • BEHAVIORAL Pain ratings
  • DEVICE Thermal stimuli
  • BEHAVIORAL Conditioned pain modulation (CPM) response
  • BIOLOGICAL Hormonal assessment

Study Locations (1)

Missouri

  • Washington University School of Medicine - St Louis

Trial Details

FieldValue
Enrollment Target 120 participants
Start Date 2025-02-12
Est. Completion 2030-01-01

What the Registry Record Tells You About NCT06785129

The ClinicalTrials.gov registry entry for NCT06785129 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 120 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 357-participant average among 102 other Migraine trials with a reported enrollment target (66% lower). The listed sponsor is Washington University School of Medicine, which has 1,502 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Migraine appearing as the primary indexed condition, and to 5 interventions - of which Pressure stimuli is the first listed.

NCT06785129 reports 1 study location spanning 1 distinct geographic area - top geographies include Missouri.

Frequently Asked Questions

What is clinical trial NCT06785129 about?

NCT06785129 is a clinical study titled "Endometriosis and Migraine". This study aims to determine differences in experimental pain and sex hormone levels between patients with migraine, patients with endometriosis, patients with migraine and endometriosis, and healthy controls. Participants will complete surveys, experimental pain paradigms and collection of samples ...

What is the current status of trial NCT06785129?

This trial is currently recruiting. The enrollment target is 120 participants. The study started on 2025-02-12. Estimated completion is 2030-01-01.

What conditions does trial NCT06785129 study?

This clinical trial studies the following conditions: Migraine, Endometriosis.

What interventions are being tested in trial NCT06785129?

The interventions under investigation include: Pressure stimuli (DEVICE), Pain ratings (BEHAVIORAL), Thermal stimuli (DEVICE), Conditioned pain modulation (CPM) response (BEHAVIORAL), Hormonal assessment (BIOLOGICAL).

Who is sponsoring clinical trial NCT06785129?

This trial is sponsored by Washington University School of Medicine, which has 1,502 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06785129 being conducted?

This trial has 1 study location across Missouri. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Migraine

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.